3D Printing for Healthcare: R&D, Industry and Market 2014-2024

LONDON, January 22, 2014 /PRNewswire/ --

Printing in three dimensions for medicine - this new analysis explains trends, technologies, and sales potentials

What's the future of additive manufacturing for medicine? That's fabricating three dimensional solid objects from digital models, via 3D printers. Visiongain's new report gives data you need there, letting you explore developments, technology, and revenue predictions.

That analysis forecasts revenues there to 2024 at overall world market, submarket, and national level. Avoid falling behind in knowledge, missing business or losing influence.

Explore, then, the commercial prospects of those computer controlled industrial robots for performing additive processes. See outlooks for medical devices, tissues, drugs and more.

Advances in manufacturing for medicine - find what that printer technology could be worth

So find potentials for those novel production tools for creating shapes and patterns - multiform designs. You explore that medical business. Now discover how you could gain.

Read on, then, to explore those products and applications, seeing what the future market could be worth.

Forecasts to 2024 and other information to help you stay ahead in knowledge

Besides revenue forecasting to 2024, our new work shows you historical data, recent results, growth rates, and market shares. There you explore research and development (R&D) too. You also get 50 tables, 50 charts, and three interviews with people in that field.

Information to help your work and save time, benefiting your authority

Is finding data on novel prototyping and production systems for health a challenge? Now make your work easier. And save time. That way you can stay ahead in knowledge, helping your research, analyses, and decisions. Also benefit your influence.

Our study lets you investigate the most promising and lucrative aspects of that producing. There you assess methods, equipment, and their uses, hearing what's going on and seeing where money lies. Try our new report, then, gaining feel for the 3D printing sector's potential.

And the following sections outline what you get in that new investigation.

To see an exec summary of this report please email Sara Peerun on sara.peerun@visiongainglobal.com

Forecasting of that world market and its main segments - what's likely to happen?

What're the secrets of that industry's progress? What's the potential of that chemistry and engineering for medicine? Discover in our report overall world revenue to 2024 for those synthetic processes for medical applications.

Also find individual revenue predictions to 2024 for six submarkets at world level:
• Technology (with sub-forecasts for dental products, medical implants, bioprinted tissue, and other uses.
• Products.

Which operations and processes will generate most money from 2014? There you assess outlooks for commercial growth, seeing where you can gain.

Our analysis helps you identify potential in that synthesis for medicine, producing complex geometries and surfaces. There, explore the best revenue-generating prospects.

And that emerging industry holds opportunity in developed and developing countries.

National markets - where will highest revenues and business expansion occur?

Needs for medical devices, diagnostics, and pharmaceuticals expand use of manufacturing technologies using 3D print methods. In our study you examine the technological and commercial scope of those developments, also exploring national opportunities.

Those analyses show you individual revenue forecasts to 2024 for 11 countries:
• United States (US)
• Japan
• Germany, France, UK, Italy, and Spain (EU5)
• Brazil, Russia, India, and China (BRIC Nations).

There you find regions with highest revenues, demand, and sales potentials for that production. Our work explains for those systems and their uses. You find international prospects, then, appraising needs and demands.

So explore how technology for multidimensional printing can benefit its developers, producers, marketers, sellers, and users. Our work shows you, discussing crucial issues.

Events and forces for developing, producing, marketing, and selling

The report explains forces affecting that industry and market from 2014, including these:
• Technologies including selective laser sintering (SLS), direct metal laser sintering (DMLS), electron beam melting (EBM), stereolithography (SLA), and bioprinting
• Orthopaedic and cranio-maxillofacial implants, medical modelling, prototypes, and pharmaceuticals
• Regulatory requirements - abridged pathways and innovation, and challenges with 3D technologies
• Intervertebral discs, bionic organs, bioengineering, skin grafts, implantable cartilage, artificial blood vessels, liver tissue, heart valves, and reconstructive surgery
• Other advances in research and development (R&D) pipelines, inc. efforts improving biocompatibility and enhanced functionality.

There you explore political, economic, social, and technological questions, investigating outlooks for business. Examine what stimulates and restrains that industry and market.

So you discover what the present and future hold for those instruments and their harnessing. See what success is possible from 2014.

To see an exec summary of this report please email Sara Peerun on sara.peerun@visiongainglobal.com

Companies and overall 2018 market value - how high can 3D shaping revenues go?

What does the future hold? Our report predicts the world market for those multidimensional printer technologies for health will generate $4043m in 2018. That analysis forecasts high sales growth there from 2014 to 2024. See what's possible.

There, corporations and specialty providers of that chemical and engineering technology can prosper. You discover how and why.

In particular, then, you explore activities and outlooks of these companies, among others:
• Tissue Regeneration Systems
• Oxford Performance Materials
• Within Technologies
• Tonrud Engineering
• Alphaform
• Arcam
• Stratasys
• 3D Systems
• Organovo.

You find 92 organisations mentioned. Also you read three interviews with authorities in the field. So find what participants do, say, and think, helping you stay ahead.

Ways 3D Printing for Healthcare: R&D, Industry and Market 2014-2024  helps you

Through data such as this, our investigation helps you get recognition for insight:
• Revenues there to 2024 at world level, and for 6 submarkets - assess outlooks for companies, their technology, marketing, and sales
• Forecasts to 2024 for 11 national markets in the Americas, Europe, and Asia - investigate leading countries for revenues and commercial expansion
• Prospects for established competitors, rising firms, and new entrants - investigate portfolios, results, strategies, developmental activities, and successes.

Knowledge found nowhere else, helping your searches, analyses, and plans

Our new report gives independent analysis. There you receive competitive intelligence found only in our work, finding where progress and money lie. Explore possibilities for business.

With that information you're less likely to fall behind in knowledge or miss opportunity. Being free to choose, you find how you could save time and effort there, helping your decisions and your influence.

Trying our report now lets you discover 3D printing opportunities and predictions

Our new report is for everyone investigating production techniques, equipment, and devices for healthcare. In it you find revenue forecasting to 2024, with opinions and discussions. So avoid missing out - please order now.

To request an exec summary of this report please email Sara Peerun at            sara.peerun@visiongainglobal.com or call Tel : +44-(0)20-7336-6100

Or click on  http://www.visiongain.com/Report/1184/3D-Printing-for-Healthcare-R-D-Industry-and-Market-2014-2024

Companies Listed in this Report:

3D Systems Corp
3T RPD
5N Plus
Adler Ortho
Alphaform AG
Aprecia Pharmaceuticals
Arcam AB
Asian Manufacturing Association (AMA)
BestinClass SA
Biomet
C&A Tool
Chinese FDA (CFDA)
Clemson University
Compass3D
Conformité Européenne (CE)
Cornell University
Deloitte
DePuy Synthes
Deutsches Herzzentrum Berlin (DHZB)
DiSanto Technology
EnvisionTEC
EOS
Ernst & Young
Expert 3D Solutions
FirstSurface Ltd.
Food and Drug Administration (US FDA)
Fraunhofer Institutes
Hangzhou Dianzi University
Harvard University
Imaginarium
Industry Alliance of China 3D Printing Technology
Invetech
Johns Hopkins University
Knight Cancer Institute
Kyoto University
Laser Zentrum Hannover
LayerWise
Lexmark
Lima Corporate
Maastricht Instruments B.V.
Massachusetts Institute of Technology (MIT)
Materialise NV
Mattel Children's Hospital
MCP HEK Tooling
Medical Modelling
Medimet GMBH
Medtronic
Michael J Fox Foundation
Ministry of Industry and Information Technology
Nakashima Medical
National Additive Manufacturing Innovation Institute (NAMII)
North Carolina State University
Nottingham University Hospitals Trust
Objet
OBL
Office of Science and Engineering Laboratories
Oregon Health and Science University
Organovo
Oxford Performance Materials (OPM)
Peking University 3rd Hospital
Pfizer
Princeton University
Protosys Technologies
Queen's Medical Centre (QMC)
Roche
Royal Perth Hospital, Australia
SIU System
SkinPrint
Smith & Nephew
Sony DADC
State Food and Drug Administration (SFDA)
Stratasys
Stryker
The Cronin Group
The Michael J Fox Foundation
Tissue Regeneration Systems
Tonrud
TU Berlin
UCLA
United Therapeutics
University of Glasgow
University of Michigan
University of North Carolina
University of Oxford
University of Pennsylvania
University of Wisconsin
Wake Forest Institute for Regenerative Medicine (WFIRM)
Walter Reed National Military Medical Center
Weill Cornell Medical College
Within Technologies
Wyss Institute for Biologically Inspired Engineering
Xilloc Medical
Zimmer

To see an exec summary of this report please email Sara Peerun on sara.peerun@visiongainglobal.com